Grovecourt Capital Partners

IMRIS is a company that designs, manufactures, and markets image-guided therapy systems aimed at enhancing the effectiveness of medical treatments. Its primary product, the VISIUS Surgical Theatre, integrates advanced imaging technologies such as magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites. This setup allows for intra-operative imaging, providing timely information to clinicians during surgical and interventional procedures. IMRIS primarily serves hospitals that offer clinical services in the neurosurgical, interventional neurovascular, spinal, and cardiovascular fields. The company operates globally, with a presence in North America, Europe, the Middle East, and the Asia-Pacific region, focusing on improving visualization and the overall therapy delivery process.

Traffic & Mobility Consultants specializes in providing comprehensive traffic engineering and transportation planning services. The company caters to both private clients and governmental agencies at various levels, offering a range of services that include traffic studies, signalization design, and due diligence investigations. Additionally, they conduct parking studies, signal warrant analyses, and develop intelligent transportation systems (ITS) designs. Their expertise extends to long-range transportation planning and detailed corridor operations analyses, ensuring effective traffic circulation and efficient signal timing coordination. With a focus on enhancing mobility and safety, Traffic & Mobility Consultants plays a vital role in the traffic and transportation engineering sector.